Viewing nowCombinationJardiance Duo Tablet 12.5/850 mg
Empagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Genupharm Co., Ltd.

MFDS item code 202302584 · Approved 2023.08.30 · Insurance code 698004730
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication helps improve blood sugar control in patients with type 2 diabetes by combining empagliflozin and metformin. It is used as an adjunct to diet and exercise therapy, and is effective in adults whose blood sugar is not adequately controlled. Additionally, the effects on the occurrence of cardiovascular events should be considered in patients with concomitant cardiovascular disease, based on expert recommendations. Overall, it is a medication that contributes to health management along with improved blood sugar control.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient’s current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; if this occurs, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication helps control blood sugar levels. However, it may cause a rare side effect known as severe lactic acidosis, which requires caution. It should not be used in patients with poor kidney function or conditions such as severe infection, dehydration, or heart failure. When used with insulin or other diabetes medications, dose adjustments may be necessary due to the risk of hypoglycemia. Prior to surgeries or radiological examinations, this medication should be stopped for a certain period, and treatment can be resumed only after confirming normal kidney function. It is advisable that pregnant or nursing women do not use this medication. Elderly patients should regularly monitor kidney function due to the risk of reduced function and may need dose adjustments. During treatment, dehydration or excessive alcohol intake should be avoided, and any symptoms should be reported to healthcare professionals immediately. Additionally, there may be an increased risk of urinary tract infections or genital infections, so prompt treatment is necessary if infection symptoms occur. Regular blood tests are recommended as B12 vitamin levels may decrease. Irregular meals or vigorous exercise should be avoided during this treatment, and patients should be aware of hypoglycemia symptoms. Overdosing this medication may result in serious side effects, therefore the prescribed dosage must be strictly followed.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container as it can degrade due to air or moisture. It is advisable to maintain the storage temperature between 1 and 30 degrees Celsius. This will help preserve the efficacy of the medication for a longer period.
White oval film-coated tablets with pink tint, convex on both sides
60 tablets/bottle, 30 tablets/bottle, 60 tablets/box [(10 tablets/PTP x 6)], 10 tablets/box [(10 tablets/PTP x 1)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Genupharm Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.